Experience of applying a new European chondroprotector in patients with stage 1–2 osteoarthritis in general medical practice
The effectiveness of the new European chondroprotector in combined therapy in the 1–2 stage of osteoarthritis (OA) of different localization was estimated. The study included 358 patients with knee and hip joint OA, as well as polyosteoartrosis. According to the study, all patients experienced a dec...
Saved in:
Main Author: | T. N. Kargaeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Open Systems Publication
2021-06-01
|
Series: | Лечащий Врач |
Subjects: | |
Online Access: | https://journal.lvrach.ru/jour/article/view/547 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effectiveness of chondroprotective therapy in patients with lumbosacral dorsopathies
by: N. V. Yakovleva, et al.
Published: (2021-06-01) -
On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis
by: I. V. Sarvilina, et al.
Published: (2024-08-01) -
Pharmacoinformation studies of chondroprotectors
by: A. M. Lila, et al.
Published: (2021-10-01) -
On the prospects for the use of undenatured type II collagen in the treatment of osteoarthritis and other joint diseases
by: O. A. Gromova, et al.
Published: (2022-08-01) -
Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy
by: O. A. Shavlovskaya, et al.
Published: (2023-11-01)